The majority of OI patients are associated with pathogenic variants in COL1A1 and COL1A2, the encoding genes of type I collagen, and the minority of OI patients are related to mutations in other genes that are involved in type I collagen biosynthesis or osteoblast differentiation or bone mineralization (3). This evidence concerns the gene COL1A2 and osteogenesis imperfecta.